Search
for
Sort by
Research 301–330 of 1000+
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Selected Disorders of Skin Appendages—Acne, Alopecia, Hyperhidrosis
- Alterations in Hair Follicle Dynamics in Women
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Dermoscopy Update: Review of its Extradiagnostic and Expanding Indications and Future Prospects
- Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function
- Common Dermatologic Conditions
- Androgenic alopecia: A counterproductive outcome of the anabolic effect of androgens
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- RNA sequence analysis of dermal papilla cells’ regeneration in 3D culture
- Advances in Hair Diseases
- Debatable Topics in PCOS Patients
- Nails and hair
- Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles
- Hereditary, Congenital, and Acquired Alopecias
- Endocrinologia e Medicina Estética Ed. X
- Exosomes derived from Umbilical cord mesenchymal stem cell promote hair regrowth in C57BL6 mice through upregulation of the RAS/ERK signaling pathway
- Hair loss: a clinical update
- Neuroendocrine Controls of Keratin Expression in Human Skin
- Nails and hair
- Diagnostik und Therapie der kutanen Androgenisierung im klimakterischen Übergang sowie in der Peri- und Postmenopause: Hirsutismus und Alopezie
- Diagnostik und Therapie bei Haarausfall und Hirsutismus
- Dermatologia e Procedimentos Estéticos Ed. XXVII
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Updates to Male Infertility: AUA/ASRM Guideline (2024)
- EMT Factors and Metabolic Pathways in Cancer
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis